Literature DB >> 20669181

Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study.

Alessandra Nicoletti1, Pierfrancesco Pugliese, Giuseppe Nicoletti, Gennarina Arabia, Grazia Annesi, Michele De Mari, Paolo Lamberti, Lucia Grasso, Roberto Marconi, Antonio Epifanio, Letterio Morgante, Autilia Cozzolino, Paolo Barone, Giusi Torchia, Aldo Quattrone, Mario Zappia.   

Abstract

We evaluated the possible association between smoking, coffee drinking, and alcohol consumption and Parkinson's disease (PD). The FRAGAMP study is a large Italian multicenter case-control study carried out to evaluate the possible role of environmental and genetic factors in PD. Adjusted ORs were estimated using unconditional logistic regression. Smoking, coffee, and alcohol consumption were also considered as surrogate markers of lifestyle and analysis was carried out considering the presence of at least one, two, or three factors. This latter analysis was separately performed considering Tremor-Dominant (TD) and Akinetic-Rigid (AR) patients. Four hundred ninety-two PD patients (292 men and 200 women) and 459 controls (160 men and 299 women) were enrolled in the study. Multivariate analysis showed a significant negative association between PD and cigarette smoking (OR 0.51; 95%CI 0.36-0.72), coffee drinking (OR 0.61; 95%CI 0.43-0.87) and wine consumption (OR 0.62; 95%CI 0.44-0.86); a significant trend dose-effect (P < 0.05) has been found for all the factors studied. We have also found a trend dose-effect for the presence of at least one, two or three factors with a greater risk reduction (83%) for the presence of three factors. However, a different strength of association between TD and AR was found with a greater risk reduction for the AR patients. We found a significant inverse association between PD smoking, coffee, and alcohol consumption. When analysis was carried out considering the association of these factors as possible surrogate markers of a peculiar lifestyle the association was stronger for the AR phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20669181     DOI: 10.1002/mds.23297

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Authors:  Gaetano Barbagallo; Maria Eugenia Caligiuri; Gennarina Arabia; Andrea Cherubini; Angela Lupo; Rita Nisticò; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Giuseppe Lucio Cascini; Domenico Galea; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

Review 2.  Multiple sclerosis in 2013: novel triggers, treatment targets and brain atrophy measures.

Authors:  Xavier Montalban; Mar Tintoré
Journal:  Nat Rev Neurol       Date:  2014-01-07       Impact factor: 42.937

3.  The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.

Authors:  Tanuja Bordia; Matthew McGregor; Roger L Papke; Michael W Decker; J Michael McIntosh; Maryka Quik
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

4.  Lifestyle, family history, and risk of idiopathic Parkinson disease: a large Danish case-control study.

Authors:  Line Kenborg; Christina F Lassen; Beate Ritz; Klaus K Andersen; Jane Christensen; Eva S Schernhammer; Johnni Hansen; Lene Wermuth; Naja H Rod; Jørgen H Olsen
Journal:  Am J Epidemiol       Date:  2015-04-29       Impact factor: 4.897

5.  Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Authors:  Francesca Morgante; Alfonso Fasano; Monia Ginevrino; Simona Petrucci; Lucia Ricciardi; Francesco Bove; Chiara Criscuolo; Marcello Moccia; Anna De Rosa; Chiara Sorbera; Anna Rita Bentivoglio; Paolo Barone; Giuseppe De Michele; Maria Teresa Pellecchia; Enza Maria Valente
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

6.  Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Alessandra Nicoletti; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  J Neurol       Date:  2016-03-10       Impact factor: 4.849

7.  Head trauma and Parkinson's disease: results from an Italian case-control study.

Authors:  Alessandra Nicoletti; Rosario Vasta; Giovanni Mostile; Giuseppe Nicoletti; Gennarina Arabia; Giovanni Iliceto; Paolo Lamberti; Roberto Marconi; Letterio Morgante; Paolo Barone; Aldo Quattrone; Mario Zappia
Journal:  Neurol Sci       Date:  2017-07-26       Impact factor: 3.307

Review 8.  Nicotine as a potential neuroprotective agent for Parkinson's disease.

Authors:  Maryka Quik; Xiomara A Perez; Tanuja Bordia
Journal:  Mov Disord       Date:  2012-06-12       Impact factor: 10.338

Review 9.  Alcohol Consumption and Parkinson's Disease Risk: A Review of Recent Findings.

Authors:  Silvana S Bettiol; Tanith C Rose; Clarissa J Hughes; Lesley A Smith
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

10.  Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder.

Authors:  Fahd Baig; Michael A Lawton; Michal Rolinski; Claudio Ruffmann; Johannes C Klein; Kannan Nithi; David Okai; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Parkinsonism Relat Disord       Date:  2017-02-01       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.